- Home
- DHT vs BHC Comparison
DHT vs BHC Comparison
Compare DHT & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- BHC
- Stock Information
- Founded
- DHT 2005
- BHC N/A
- Country
- DHT Bermuda
- BHC Canada
- Employees
- DHT N/A
- BHC N/A
- Industry
- DHT Marine Transportation
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- DHT Consumer Discretionary
- BHC Health Care
- Exchange
- DHT Nasdaq
- BHC Nasdaq
- Market Cap
- DHT 1.9B
- BHC 2.2B
- IPO Year
- DHT 2005
- BHC N/A
- Fundamental
- Price
- DHT $13.10
- BHC $6.61
- Analyst Decision
- DHT Strong Buy
- BHC Hold
- Analyst Count
- DHT 2
- BHC 2
- Target Price
- DHT $15.00
- BHC $9.00
- AVG Volume (30 Days)
- DHT 1.9M
- BHC 1.7M
- Earning Date
- DHT 10-29-2025
- BHC 10-29-2025
- Dividend Yield
- DHT 7.28%
- BHC N/A
- EPS Growth
- DHT 22.62
- BHC N/A
- EPS
- DHT 1.23
- BHC 0.27
- Revenue
- DHT $539,541,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- DHT N/A
- BHC $6.28
- Revenue Next Year
- DHT $34.29
- BHC $3.76
- P/E Ratio
- DHT $11.16
- BHC $22.24
- Revenue Growth
- DHT N/A
- BHC 7.13
- 52 Week Low
- DHT $8.67
- BHC $4.25
- 52 Week High
- DHT $13.19
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- DHT 65.59
- BHC 51.80
- Support Level
- DHT $12.39
- BHC $5.88
- Resistance Level
- DHT $13.19
- BHC $6.45
- Average True Range (ATR)
- DHT 0.34
- BHC 0.22
- MACD
- DHT 0.13
- BHC 0.03
- Stochastic Oscillator
- DHT 91.95
- BHC 94.78
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. The group generates revenues from time charter and spot market operations. It operates through integrated management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from the shipping revenues.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.